Edwards Lifesciences Corp (EW) support and resistance · P/E 47, rev $1.39B
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
This page maps Edwards Lifesciences Corp (EW) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
EW currently screens at market cap $49.91B and trailing P/E 46.9. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new EW 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the EW quote page for the session range and the stock page for the full model.
Not investment advice.